It’s not easy to get depression-detecting AI through the FDA
Seven years. $millions invested. Kintsugi's depression-detecting AI just hit the FDA wall and shut down.

Why it matters
Regulatory hurdles remain a major obstacle for healthcare AI startups, even with promising technology. Kintsugi's failure to secure FDA clearance after 7 years highlights the challenges of bringing mental health AI to market.
The key facts
4 to knowSeven years of development
Company shutting down due to FDA clearance failure
Technology being released as open-source
Pivot potential to deepfake audio detection
Go to the source
The Verge AItheverge.com
Publisher excerpt: For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some…

